Gadobutrol
Top View
- Safety of Gadobutrol in More Than 1000 Pediatric
- Chapter 1: Introduction and Background…………………………………………….…...1
- Late Diagnosis of Anaphylactic Reaction to Gadolinium-Based
- Gadolinium Containing Contrast Agents
- Gadolinium-Based Contrast Media Nephrotoxicity in Kidney Impairment: the Physio-Pathological Conditions for the Perfect Murder
- Manual on Contrast Media Version 7 2010
- Gadovist®) Stuerzebecher A, Prasa D, Deters M, Hentschel H Poisons Information Centre Erfurt, Germany
- Proprietary Name Review(S)
- Risk of Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents
- Safety Evaluation of Linear and Macrocyclic Gadolinium-Based
- Intrathecal Use of Gadobutrol for Glymphatic MR Imaging: Prospective Safety Study of 100 Patients
- Provisional Peer-Reviewed Toxicity Values for Stable (Nonradioactive) Gadolinium (Casrn 7440-54-2) and Soluble Salts
- Comprehensive Contrast Policy Page 2 of 25
- Safety of Gadobutrol in Over 23,000 Patients: the GARDIAN Study, a Global Multicentre, Prospective, Non-Interventional Study
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Pharmacologyonline 3: 728-781 (2010) Newsletter Bradu and Rossini
- Standards for Intravascular Contrast Administration to Adult Patients
- Safety and Clinical Usefulness of Gadoteric Acid Including Post-Marketing Surveillance